COVID-19-Associated Pulmonary Mucormycosis
COVID-19-associated mucormycosis (CAM) emerged as an epidemic in certain parts of the world amidst the global COVID-19 pandemic. While rhino–orbital mucormycosis was well reported during the pandemic, in the absence of routine diagnostic facilities including lower airway sampling, pulmonary mucormyc...
Main Authors: | Vidya Krishna, Nitin Bansal, Jaymin Morjaria, Sundeep Kaul |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/8/7/711 |
Similar Items
-
Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infection
by: Vidya Krishna, et al.
Published: (2021-01-01) -
Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes
by: Omer Sefvan Janjua, et al.
Published: (2021-12-01) -
The Double-Edged Sword of Immunosuppressive Therapy in Kidney Transplantation: A Rare Case Report of Pulmonary Mucormycosis Post-Transplant and Literature Review
by: Hengcheng Zhang, et al.
Published: (2020-09-01) -
Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic
by: Ravindra M Mehta, et al.
Published: (2022-01-01) -
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
by: Asim Azhar, et al.
Published: (2022-04-01)